In modern dermatology, we are increasingly witnessing a recurring scene: a patient arrives for a follow-up visit, clutching their phone to display a list of “unsafe” sunscreens generated by organizations like the Environmental Working Group (EWG). Driven by genuine fear of ingredients labeled as “toxic” or “endocrine-disrupting,” patients are ditching clinically proven sunscreens in favor of viral DIY recipes like coconut oil and beeswax. While it is heartening that patients are taking an interest in their health, the disconnect between advocacy-driven hazard assessments and medical reality is putting lives at risk. When patients prioritize unproven digital headlines over the expertise of their physicians, they trade the known, manageable risk of chemical exposure for the catastrophic, life-altering threat of melanoma and DNA damage.
To navigate this landscape, it is essential for patients to understand the difference between a regulatory body and an advocacy group. The EWG is a non-governmental organization that uses a proprietary scoring system to rate products, a system that lacks the medical consensus and rigorous peer-review standards required by the FDA, the American Academy of Dermatology, or the American Cancer Society. Because these ratings often prioritize hazard—or the mere presence of a substance—over actual clinical risk, they create a distorted reality. We must ask ourselves whether we are making medical decisions based on objective, repeatable science or on marketing narratives that thrive on fear. As dermatologists, our role is to act as a bridge, helping patients distinguish between the sensationalized “noise” of the internet and the clinical evidence that actually shapes longevity and skin health.
A major point of confusion for many patients is the concept of systemic absorption. Yes, in lab settings, some sunscreen chemicals have been detected in the blood under optimal, maximized conditions. However, finding a chemical in the blood is not synonymous with toxicity, nor is it a sign that one should abandon sun protection. The FDA tracks these levels to ensure safety, not to suggest that sunscreen as a product is inherently dangerous. In contrast, the dangers of UV radiation are not theoretical; they are well-documented drivers of skin cancer and photoaging. We frequently see the devastating results of ultraviolet damage in our surgical clinics, and it is here that the distinction between a perceived hazard and a real-world medical risk becomes painfully clear.
The debate over high SPF ratings, such as those above SPF 50, further illustrates the gap between “perfect” chemistry and human behavior. While laboratory tests might show diminishing returns for very high SPF, the real world is rarely a laboratory. Most people do not apply the recommended amount of sunscreen, nor do they reapply it as frequently as they should. In practice, a higher SPF provides a vital “buffer” for these inevitable human errors—thin application, sweating, or missed spots—offering a larger margin of safety for the user. Arguing against high SPF products based on idealized models ignores the chaotic, messy reality of daily life, where a higher degree of protection is often the only thing standing between a patient and a severe sunburn.
Furthermore, we must address the regulatory bottlenecks that have historically plagued the U.S. sunscreen market. For years, the FDA’s slow approval process created a false impression that our options were limited or outdated. Fortunately, recent progress, such as the authorization of more stable UV filters like bemotrizinol, shows that the system is beginning to adapt. While we wait for these updates to become commonplace, we continue to counsel patients with empathy rather than judgment. For those who remain anxious about chemical filters, mineral-based options like zinc oxide are wonderful alternatives. The most important lesson is that valid concern should never lead to the use of ineffective, homemade “potions” that offer no protection against radiation, leaving the skin entirely vulnerable to damage.
Ultimately, the goal of dermatology is not to defend a brand or a product segment, but to secure the long-term health of our patients. Good clinical care requires us to acknowledge a patient’s fears without confirming inaccuracies. By shifting the conversation away from fear-based ingredient lists and toward comprehensive sun protection—which includes shade, protective clothing, hats, and the consistent use of any SPF the patient is willing to wear—we can reclaim the narrative. We must remind our patients that they are partners in their own health, and that in the balance between modern chemical safety and the harsh reality of UV exposure, science remains their greatest, and most reliable, ally.